Laurence N Charney insider trades: Tg Therapeutics (TGTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Laurence reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | TGTX | ↓ Sell | 5,000 | $54.96 | $275K | Direct | Sep 14, 2026 (4d) |
| Nov 11, 2024 | TGTX | ↓ Sell | 25,000 | $30.20 | $755K | Direct | Nov 12, 2024 (1d) |
| Mar 12, 2024 | TGTX | ↓ Sell | 22,000 | $15.97 | $351K | Direct | Mar 13, 2024 (1d) |
| Jan 5, 2024 | TGTX | ↓ Sell | 17,500 | $19.03 | $333K | Direct | Jan 8, 2024 (3d) |
| Jan 4, 2023 | TGTX | ↓ Sell | 30,000 | $11.10 | $333K | Direct | Jan 6, 2023 (2d) |
| Apr 4, 2017 | TGTX | ↓ Sell | 7,000 | $11.17 | $78K | Direct | Apr 4, 2017 (0d) |
| Nov 28, 2012 | ICON | ↓ Sell | 5,000 | $19.73 | $99K | Direct | Nov 30, 2012 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TGTX insiders
Open-market trades in the last 12 months
About Laurence N Charney's insider trades
Laurence N Charney is a director at Tg Therapeutics (TGTX). Since Nov 28, 2012, Laurence has reported no open-market purchases and 7 sales worth $2.2M on SEC Form 4. In the last 12 months: 1 sale ($275K).
Their filings also include grants and awards (22 filings), gifts (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TGTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.